Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: A …

S Shirvalilou, S Khoei, AJ Esfahani, M Kamali… - Journal of Neuro …, 2021 - Springer
Introduction Hyperthermia therapy (HT) is a recognized treatment modality, that can
sensitize tumors to the effects of radiotherapy (RT) and chemotherapy by heating up tumor …

Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a …

S Shirvalilou, S Khoei, AJ Esfahani… - Journal of neuro …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Hyperthermia therapy (HT) is a recognized treatment modality, that can
sensitize tumors to the effects of radiotherapy (RT) and chemotherapy by heating up tumor …

Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a …

S Sakine, K Samideh, AJ Esfahani… - Journal of Neuro …, 2021 - search.proquest.com
Methods Five databases, PubMed/Medline, Embace, Ovid, WOS, and Scopus, were
investigated to identify clinical studies comparing overall survival (OS) following …

Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a …

S Shirvalilou, S Khoei, AJ Esfahani… - Journal of Neuro …, 2021 - search.ebscohost.com
Introduction: Hyperthermia therapy (HT) is a recognized treatment modality, that can
sensitize tumors to the effects of radiotherapy (RT) and chemotherapy by heating up tumor …

Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a …

S Shirvalilou, S Khoei, AJ Esfahani… - Journal of Neuro …, 2021 - europepmc.org
Methods Five databases, PubMed/Medline, Embace, Ovid, WOS, and Scopus, were
investigated to identify clinical studies comparing overall survival (OS) following …